NCT02814604 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Committee on Examination of Front-of-Package Nutrition Rating Systems and Symbols (Phase II), Institute of Medicine
Front-of-Package Nutrition Rating Systems and Symbols: Promoting Healthier Choices. 2011 October 20.
Emrich TE, Qi Y, Mendoza JE, Lou W, Cohen JE, L'abbé MR
Consumer perceptions of the Nutrition Facts table and front-of-pack nutrition rating systems. Appl Physiol Nutr Metab. 2014 Apr;39(4):417-24. doi: 10.1139/apnm-2013-0304. Epub 2013 Oct 24.
Key TJ, Schatzkin A, Willett WC, Allen NE, Spencer EA, Travis RC
Diet, nutrition and the prevention of cancer. Public Health Nutr. 2004 Feb;7(1A):187-200. Review.
The Standing Committee on Health
Healthy Weights for Healthy Kids. 2007

FoodFLIP: Testing the Effectiveness of a Food Information App to Promote the Selection of Healthier Foods

Clinical trial NCT02814604 - References